STML - Stemline Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Stemline Therapeutics's activity chart (see below) currently has 41 price targets and 40 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 8.57% with an average time for these price targets to be met of 11.6 days.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 05-May-2020. First documented stock forecast 29-Aug-2013.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 05-May-2020

$12.5

$0.67 (5.66%)

6 years 5 months 29 days ago
(05-May-2020)

0/5 (0%)

$0.41 (3.39%)

Buy Since 20-Mar-2017

$12.5

$0.67 (5.66%)

$41

6 years 5 months 29 days ago
(05-May-2020)

0/2 (0%)

$0.41 (3.39%)

Hold Since 04-May-2020

$11

$-0.83 (-7.02%)

6 years 5 months 30 days ago
(04-May-2020)

0/4 (0%)

$-1.11 (-9.17%)

Buy Since 24-Dec-2019

$10

6 years 5 months 30 days ago
(04-May-2020)

1/2 (50%)

$5.6 (127.27%)

38

Buy Since 26-Nov-2018

$9

$-2.83 (-23.92%)

$25

6 years 7 months 18 days ago
(16-Mar-2020)

1/7 (14.29%)

$4.94 (121.67%)

49

Show more analysts

Please expand the browser size to see the chart

What is STML (Stemline Therapeutics) average time for price targets to be met?

On average it took 12 days for the stock forecasts to be reached, with an average price target met ratio of 8.57%.

Which analyst most recently updated their price target on STML (Stemline Therapeutics)?

Raghuram Selvaraju

Which analyst has the most public recommendations on STML (Stemline Therapeutics)?

Raghuram Selvaraju has 79 price targets and 53 ratings on STML

Which analyst is the currently most bullish on STML (Stemline Therapeutics)?

Thomas Wei with the highest potential upside of $38.17

Which analyst is the currently most reserved on STML (Stemline Therapeutics)?

Joseph Catanzaro with the lowest potential downside of -$2.83
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?